Tudorza reduces exacerbations in COPD patients
AstraZeneca has announced positive top-line results of the Phase IV…
AstraZeneca has announced positive top-line results of the Phase IV ASCENT trial for Tudorza Pressair in patients with moderate to very severe COPD...